Novo Nordisk continues diabetes, obesity sales rise, but still on the back foot with Wegovy supply - Endpoints News endpts.com Submitted by endpointsnews6292 on February 1, 2024 at 12:32 PM in business No comments 15
Is CG Oncology's IPO a benchmark for a better year in public offerings? - Endpoints News endpts.com Submitted by endpointsnews6292 on January 26, 2024 at 4:26 PM in business No comments 45
CG Oncology kickstarts 2024 biotech IPO class with $380M listing - Endpoints News endpts.com Submitted by endpointsnews6292 on January 26, 2024 at 2:00 AM in business No comments 26
FDA tells CAR-T makers to add boxed warnings of secondary cancer – Endpoints News - Endpoints News endpts.com Submitted by endpointsnews6292 on January 24, 2024 at 10:55 AM in business No comments 61
Sanofi to acquire Inhibrx for $1.7B - Endpoints News endpts.com Submitted by endpointsnews6292 on January 24, 2024 at 8:20 AM in business No comments 29
Novartis' TV ad for breast cancer drug Kisqali draws untitled letter from FDA - Endpoints News endpts.com Submitted by endpointsnews6292 on January 23, 2024 at 6:23 PM in health No comments 50
Bayer to make significant cuts, rolls out new model at 'expense of many managerial employees' - Endpoints News endpts.com Submitted by endpointsnews6292 on January 18, 2024 at 8:52 PM in business No comments 6
FDA approves Vertex and CRISPR's Casgevy as first CRISPR-edited therapy for beta-thalassemia - Endpoints News endpts.com Submitted by endpointsnews6292 on January 17, 2024 at 7:00 PM in business No comments 41
Doudna's new venture; Aclaris CEO to step down; Tome's $114M liver disorder deal with Genevant - Endpoints News endpts.com Submitted by endpointsnews6292 on January 17, 2024 at 4:09 PM in health No comments 48
The Bell Labs of biotech: Stuart Schreiber has billionaire support for new biomedical institute - Endpoints News endpts.com Submitted by endpointsnews6292 on January 13, 2024 at 4:01 PM in business No comments 19
GSK to buy asthma biotech Aiolos Bio for up to $1.4B three months after startup emerged: #JPM24 - Endpoints News endpts.com Submitted by endpointsnews6292 on January 10, 2024 at 7:56 AM in business No comments 30
New David Liu study details virus-like delivery system for prime editing - Endpoints News endpts.com Submitted by endpointsnews6292 on January 9, 2024 at 10:00 AM in health No comments 54
Exclusive: Alphabet's Isomorphic inks first pharma deals with Eli Lilly and Novartis for $83M upfront, $2.9B in milestones - Endpoints News endpts.com Submitted by endpointsnews6292 on January 8, 2024 at 5:00 PM in business No comments 43
Novartis doubles down on neurologic gene therapy work with Voyager - Endpoints News endpts.com Submitted by endpointsnews6292 on January 3, 2024 at 12:34 PM in business No comments 18
Grail has big plans for its blood cancer tests. The first step: Finding a new owner - Endpoints News endpts.com Submitted by endpointsnews6292 on December 21, 2023 at 7:00 PM in business No comments 20
How Eli Lilly is rolling out Zepbound, the weight loss drug that can 'sell itself' - Endpoints News endpts.com Submitted by endpointsnews6292 on December 20, 2023 at 5:48 PM in health No comments 11
Lilly, Novo's bet on heart disease starts to take shape, and 2024 could be a pivotal year for their GLP-1s - Endpoints News endpts.com Submitted by endpointsnews6292 on December 20, 2023 at 4:24 PM in news No comments 9
Structure's oral GLP-1 a 'work in progress' following Phase IIa obesity and diabetes data - Endpoints News endpts.com Submitted by endpointsnews6292 on December 19, 2023 at 12:30 PM in business No comments 34
Bernie Sanders says he will bring legislation to reduce prescription drug costs by 50% - Endpoints News endpts.com Submitted by endpointsnews6292 on December 15, 2023 at 7:19 PM in health No comments 2
'Wonderful Christmas gift': Fed's surprise rate-cut plan springs hope of 2024 biotech market rebound - Endpoints News endpts.com Submitted by endpointsnews6292 on December 15, 2023 at 4:43 PM in business No comments 24
Sanofi R&D day: CEO Paul Hudson touts 12 blockbusters, ups R&D spend - Endpoints News endpts.com Submitted by endpointsnews6292 on December 8, 2023 at 3:55 PM in business No comments 24
Merck details PhII TIGIT/PD-1 fail in lung cancer - Endpoints News endpts.com Submitted by endpointsnews6292 on December 8, 2023 at 12:15 PM in business No comments 18
AbbVie makes second deal in a week, betting $8.7B in cash on CNS biotech Cerevel - Endpoints News endpts.com Submitted by endpointsnews6292 on December 7, 2023 at 9:47 PM in business No comments 57
J&J promises 20 new drugs to back pharma growth through end of decade, as John Reed shares his plans - Endpoints News endpts.com Submitted by endpointsnews6292 on December 6, 2023 at 12:15 PM in business No comments 60
Feng Zhang's latest gene editing trawl reels in 188 new CRISPR systems - Endpoints News endpts.com Submitted by endpointsnews6292 on November 28, 2023 at 4:24 PM in science No comments 41